Indication
Cefepime SPI is indicated in the treatment of infections caused by bacteria susceptible to cefepime, namely:
- lower respiratory tract infections, including nosocomial pneumonia and community acquired pneumonia, acute bacterial exacerbation of chronic bronchitis and secondary bacterial infection of acute bronchitis;
- uncomplicated and complicated urinary tract infections, including pyelonephritis;
- skin and subcutaneous tissue infection;
- intrabdominal infection, including peritonitis, and biliary tract infections;
- gynecological infections;
- bacterial meningitis in infants and children;
- in combination with other antibacterial agents in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection;
- treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.
